Efficacy and Safety of Exosomes from Whartons Jelly-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury
Journal of Clinical Transplantation · 2025
DOI: 10.52338/joct.2025.5082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Transplantation, 2025. Verfasst von E.C. Savrunlu und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Savrunlu, E., Kabataş, S., Civelek, E., Kaplan, N., Boyalı, O., Bozkurt, M., Küçükçakır, N., & Karaöz, E. (2025). Efficacy and Safety of Exosomes from Whartons Jelly-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury. Journal of Clinical Transplantation. https://doi.org/10.52338/joct.2025.5082
Vancouver
Savrunlu E, Kabataş S, Civelek E, Kaplan N, Boyalı O, Bozkurt M, et al. Efficacy and Safety of Exosomes from Whartons Jelly-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury. Journal of Clinical Transplantation. 2025. doi:10.52338/joct.2025.5082
BibTeX
@article{Savrunlu2025,
author = {Savrunlu, E.C. and Kabataş, S. and Civelek, E. and Kaplan, N. and Boyalı, Osman and Bozkurt, M. and Küçükçakır, N. and Karaöz, Erdal},
title = {Efficacy and Safety of Exosomes from Whartons Jelly-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury},
journal = {Journal of Clinical Transplantation},
year = {2025},
doi = {10.52338/joct.2025.5082}
}
EUVIMED